Telstar’s office in North America starts a new stage with relocation of their office to a new, larger structure in Bensalem PA. Telstar has been present in North America since the early 90’s from a facility in Bristol PA but it needs a larger site to accommodate their expanding business. Telstar North America is carrying out all activities in the new office from 31st of May 2021.

This new stage assures the company sustained organic growth and enables the company to address an increasing continuous demand for Telstar’s technology in North America. Specialized in aseptic process solutions for pharmaceutical, biotechnology and associated sectors, Telstar has been experiencing substantial growth in demand for Life Sciences service & product-based solutions in the North American market. In addition, Telstar offers the consolidation of an innovative, global customer-service team specializing in retrofitting, optimization and upgrading of GMP process equipment to assist local pharmaceutical companies.

Telstar brand has a solid reputation in North America as a leader in GMP production technology in the U.S. market. Acknowledged for the development of integrated pharmaceutical processing innovative systems based on freeze-drying, sterilization and clean air technologies besides isolation & barrier systems, the company is focusing on a solid strategy of customer management mainly made up from multinational and engineering companies while endorsing them with added value solutions in terms of quality efficiency and innovation for their projects. Another important goal is to grow the business in the service field and to incorporate the full management of commissioning of all the projects to be installed in North America.

The company, part of the Azbil Group, specializes in the development of highly complex projects, from integrated process equipment to design, engineering and construction of complete turnkey pharmaceutical and biotech production facilities, critical installations, clean rooms, and R&D laboratories.

Telstar, which invests 3% of its turnover in research, development and innovation of its technologies and equipment, operates in over one hundred countries and has four production plants, seven technology centres and 11 consultancy and engineering services centres, as well as commercial offices all over the world. It has manufacturing plants in Spain, China and the United Kingdom. Headquartered in Terrassa (Barcelona, Spain), it has a workforce of 900 people.

For more information:

TELSTAR

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream